Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding XBiotech Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of XBIT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders53155+3
Shares4.72M24.9K4.48M−213.1K (−4.5%)
Value$18.6M$98.3K$14.5M−$4.02M (−21.7%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held XBiotech Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to XBIT in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC24,879$80.6K0.00%
Two Sigma Advisers, LP17,400$56.4K0.00%
HSBC Holdings PLC15,984$51.6K0.00%
Intech Investment Management LLC14,156$45.9K0.00%
UBS Asset Management Americas Inc13,500$43.7K0.00%
Two Sigma Investments, LP12,393$40.2K0.00%
EverSource Wealth Advisors, LLC13$420.00%
True Wealth Design, LLC5$170.00%
Avion Wealth72$00.00%

Sold out (6)

Institutions that held XBiotech Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of XBIT in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Virtu Financial LLC14,735$58.0K
Group One Trading, L.P.7,500$29.6K
GAMMA Investing LLC151$596
US Bancorp100$395
Citadel Advisors LLC13$51
IFP Advisors, Inc2$8

Not filed for Q1 2025 yet (1)

Institutions that held XBiotech Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XBIT in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC24,879$98.3K